OXYGENTAPHPharmaceuticals
Oxygenta Pharmaceutical Ltd — Balance Sheet
₹48.38
-3.44%
Oxygenta Pharmaceutical Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 3.70 Cr | 3.35 Cr | 1.42 Cr | 1.42 Cr | — |
| Share Issued | 3.70 Cr | 3.35 Cr | 1.42 Cr | 1.42 Cr | — |
| Net Debt | 62.23 Cr | 57.23 Cr | 67.98 Cr | 52.06 Cr | — |
| Total Debt | 62.23 Cr | 57.23 Cr | 67.99 Cr | 52.13 Cr | — |
| Tangible Book Value | -25.64 Cr | -20.12 Cr | -46.20 Cr | -34.63 Cr | — |
| Invested Capital | 36.59 Cr | 37.11 Cr | 21.79 Cr | 17.50 Cr | — |
| Working Capital | -54.90 Cr | -9.59 Cr | -7.89 Cr | 1.50 Cr | — |
| Net Tangible Assets | -25.64 Cr | -20.12 Cr | -46.20 Cr | -34.63 Cr | — |
| Common Stock Equity | -25.64 Cr | -20.12 Cr | -46.20 Cr | -34.63 Cr | — |
| Total Capitalization | -4.12 Cr | 28.88 Cr | 16.05 Cr | 16.41 Cr | — |
| Total Equity Gross Minority Interest | -25.64 Cr | -20.12 Cr | -46.20 Cr | -34.63 Cr | — |
| Stockholders Equity | -25.64 Cr | -20.12 Cr | -46.20 Cr | -34.63 Cr | — |
| Other Equity Interest | -62.62 Cr | 0.56 Cr | -60.40 Cr | -48.83 Cr | — |
| Capital Stock | 36.98 Cr | 33.48 Cr | 14.20 Cr | 14.20 Cr | — |
| Common Stock | 36.98 Cr | 33.48 Cr | 14.20 Cr | 14.20 Cr | — |
| Total Liabilities Net Minority Interest | 108.44 Cr | 83.31 Cr | 100.46 Cr | 65.81 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 22.60 Cr | 49.62 Cr | 67.57 Cr | 57.74 Cr | — |
| Long Term Debt And Capital Lease Obligation | 21.52 Cr | 49.00 Cr | 62.25 Cr | 51.04 Cr | — |
| Long Term Debt | 21.52 Cr | 49.00 Cr | 62.25 Cr | 51.04 Cr | — |
| Long Term Provisions | 1.08 Cr | 0.62 Cr | 0.59 Cr | 2.50 Cr | — |
| Current Liabilities | 85.85 Cr | 33.70 Cr | 32.90 Cr | 8.07 Cr | — |
| Other Current Liabilities | 15.11 Cr | 0.28 Cr | 0.44 Cr | 0.32 Cr | — |
| Current Debt And Capital Lease Obligation | 40.71 Cr | 8.23 Cr | 5.74 Cr | 1.09 Cr | — |
| Current Debt | 40.71 Cr | 8.23 Cr | 5.74 Cr | 1.09 Cr | — |
| Current Provisions | 0.23 Cr | — | 0.52 Cr | 0.12 Cr | 0.09 Cr |
| Payables | 29.79 Cr | 24.45 Cr | 26.15 Cr | 6.52 Cr | — |
| Accounts Payable | 29.79 Cr | 22.89 Cr | 23.78 Cr | 6.46 Cr | — |
| Total Assets | 82.80 Cr | 63.19 Cr | 54.26 Cr | 31.18 Cr | — |
| Total Non Current Assets | 51.86 Cr | 39.09 Cr | 29.26 Cr | 21.61 Cr | — |
| Non Current Deferred Taxes Assets | 12.98 Cr | 8.73 Cr | 0.00 | — | — |
| Investmentin Financial Assets | 0.73 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | — |
| Available For Sale Securities | 0.73 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | — |
| Goodwill And Other Intangible Assets | 0.00 | — | 0.00 | — | — |
| Goodwill | 0.00 | — | — | — | — |
| Net PPE | 37.06 Cr | 29.36 Cr | 27.91 Cr | 20.32 Cr | — |
| Gross PPE | 37.06 Cr | 50.53 Cr | 46.43 Cr | 36.78 Cr | — |
| Construction In Progress | 0.23 Cr | 0.00 | 0.00 | 0.34 Cr | — |
| Other Properties | 36.83 Cr | 1.34 Cr | 1.25 Cr | 1.21 Cr | — |
| Current Assets | 30.94 Cr | 24.11 Cr | 25.01 Cr | 9.56 Cr | — |
| Other Current Assets | 5.21 Cr | -1000.00 | 3.04 Cr | -1.00 | — |
| Inventory | 20.51 Cr | 13.72 Cr | 11.71 Cr | 7.28 Cr | — |
| Accounts Receivable | 5.10 Cr | 7.36 Cr | 10.16 Cr | 1.58 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.12 Cr | 0.10 Cr | 0.11 Cr | 0.16 Cr | — |
| Other Short Term Investments | 0.12 Cr | 0.10 Cr | 0.09 Cr | 0.08 Cr | — |
| Cash And Cash Equivalents | 17000.00 | 17000.00 | 0.02 Cr | 0.07 Cr | — |
| Capital Lease Obligations | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | — | -63.88 Cr | -60.40 Cr | -48.83 Cr | -48.22 Cr |
| Additional Paid In Capital | — | 9.64 Cr | 0.00 | 0.00 | 0.00 |
| Other Non Current Liabilities | — | -1000.00 | -1000.00 | 0.40 | 0.60 |
| Non Current Deferred Taxes Liabilities | — | 0.00 | 1.66 Cr | 1.46 Cr | 1.34 Cr |
| Long Term Capital Lease Obligation | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Capital Lease Obligation | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.07 Cr | 0.57 Cr | 0.14 Cr | 0.09 Cr |
| Other Payable | — | 1.56 Cr | 2.37 Cr | 0.06 Cr | 0.49 Cr |
| Other Non Current Assets | — | -1000.00 | -1000.00 | 1.00 | — |
| Non Current Prepaid Assets | — | 0.53 Cr | 0.48 Cr | 0.87 Cr | 0.69 Cr |
| Accumulated Depreciation | — | -21.18 Cr | -18.52 Cr | -16.46 Cr | -14.87 Cr |
| Machinery Furniture Equipment | — | 41.17 Cr | 37.95 Cr | 29.28 Cr | 25.63 Cr |
| Buildings And Improvements | — | 7.85 Cr | 7.04 Cr | 5.77 Cr | 4.27 Cr |
| Land And Improvements | — | 0.18 Cr | 0.18 Cr | 0.18 Cr | 0.18 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 0.46 Cr | 0.99 Cr | 0.33 Cr | 0.40 Cr |
| Inventories Adjustments Allowances | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Inventories | — | 1000.00 | — | — | — |
| Finished Goods | — | 5.27 Cr | 5.33 Cr | 1.22 Cr | 6.11 Cr |
| Work In Process | — | 4.21 Cr | 2.63 Cr | 2.10 Cr | 1.75 Cr |
| Raw Materials | — | 4.24 Cr | 3.75 Cr | 3.97 Cr | 4.25 Cr |
| Taxes Receivable | — | 2.47 Cr | 2.04 Cr | 0.22 Cr | 1.38 Cr |
| Cash Financial | — | 17000.00 | 0.02 Cr | 0.07 Cr | 0.37 Cr |
| Tradeand Other Payables Non Current | — | — | 3.07 Cr | 2.73 Cr | 5.35 Cr |
| Allowance For Doubtful Accounts Receivable | — | — | — | 0.00 | 0.00 |
| Gross Accounts Receivable | — | — | — | 1.58 Cr | 1.61 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | — | — | — | 0.47 Cr |
| Current Deferred Taxes Liabilities | — | — | — | — | 1.34 Cr |
| Other Receivables | — | — | — | — | 0.04 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Oxygenta Pharmaceutical Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.